127 related articles for article (PubMed ID: 20668597)
1. Palliative Benefits of the Multimodality Approach in the Re-treatment of Recurrent Malignant Glioma: Two Case Reports.
Tr A; Mg J; S N
Indian J Palliat Care; 2009 Jul; 15(2):159-61. PubMed ID: 20668597
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
Minniti G; Scaringi C; De Sanctis V; Lanzetta G; Falco T; Di Stefano D; Esposito V; Enrici RM
J Neurooncol; 2013 Jan; 111(2):187-94. PubMed ID: 23129347
[TBL] [Abstract][Full Text] [Related]
3. Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage.
Shen CJ; Kummerlowe MN; Redmond KJ; Martinez-Gutierrez JC; Usama SM; Holdhoff M; Grossman SA; Laterra JJ; Strowd RE; Kleinberg LR
Adv Radiat Oncol; 2018; 3(4):582-590. PubMed ID: 30370358
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of temozolomide and reirradiation using conformal 3D-radiotherapy in recurrent brain gliomas.
Osman MA
Ann Transl Med; 2014 May; 2(5):44. PubMed ID: 25333019
[TBL] [Abstract][Full Text] [Related]
6. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
[TBL] [Abstract][Full Text] [Related]
7. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
8. Irradiation and bevacizumab in high-grade glioma retreatment settings.
Niyazi M; Ganswindt U; Schwarz SB; Kreth FW; Tonn JC; Geisler J; la Fougère C; Ertl L; Linn J; Siefert A; Belka C
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):67-76. PubMed ID: 21030162
[TBL] [Abstract][Full Text] [Related]
9. Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma.
Minniti G; Armosini V; Salvati M; Lanzetta G; Caporello P; Mei M; Osti MF; Maurizi RE
J Neurooncol; 2011 Jul; 103(3):683-91. PubMed ID: 21052773
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H
Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724
[TBL] [Abstract][Full Text] [Related]
11. A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
Dixit KS; Sachdev S; Amidei C; Kumthekar P; Kruser TJ; Gondi V; Grimm S; Lukas RV; Nicholas MK; Chmura SJ; Fought AJ; Mehta M; Raizer JJ
J Neurooncol; 2021 Dec; 155(3):297-306. PubMed ID: 34689306
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma.
Kocher M; Kunze S; Eich HT; Semrau R; Müller RP
Strahlenther Onkol; 2005 Mar; 181(3):157-63. PubMed ID: 15756519
[TBL] [Abstract][Full Text] [Related]
13. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
[TBL] [Abstract][Full Text] [Related]
14. Carbon Ion Beam Reirradiation in Recurrent High-Grade Glioma.
Eberle F; Lautenschläger S; Engenhart-Cabillic R; Jensen AD; Carl B; Stein M; Debus J; Hauswald H
Cancer Manag Res; 2020; 12():633-639. PubMed ID: 32095084
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of reirradiation for patients with recurrent rectal carcinoma.
Mohiuddin M; Marks G; Marks J
Cancer; 2002 Sep; 95(5):1144-50. PubMed ID: 12209702
[TBL] [Abstract][Full Text] [Related]
16. Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide.
Kleinberg L
Core Evid; 2012; 7():115-30. PubMed ID: 23118709
[TBL] [Abstract][Full Text] [Related]
17. Survival following reirradiation using intensity-modulated radiation therapy with temozolomide in selected patients with recurrent high grade gliomas.
Aktan M; Koc M; Kanyilmaz G
Ann Transl Med; 2015 Nov; 3(20):304. PubMed ID: 26697464
[TBL] [Abstract][Full Text] [Related]
18. External beam radiation dose escalation for high grade glioma.
Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
[TBL] [Abstract][Full Text] [Related]
19. Moderately Hypofractionated Radio(chemo)therapy With Simultaneous Integrated Boost for Recurrent, Previously Irradiated, High-grade Glioma.
Graen P; Christiansen H; Polemikos M; Heetfeld C; Feuerhake F; Wiese B; Merten R
Anticancer Res; 2023 May; 43(5):2155-2160. PubMed ID: 37097672
[TBL] [Abstract][Full Text] [Related]
20. Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
Fleischmann DF; Unterrainer M; Corradini S; Rottler M; Förster S; la Fougère C; Siepmann T; Schwaiger M; Bartenstein P; Belka C; Albert NL; Niyazi M
PLoS One; 2019; 14(7):e0216111. PubMed ID: 31339892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]